Targeting Inflammasome with stable endocannabinoid ligand AMG315. CRISPR/Cas9 and nanotechnology study in the context of HIV and cannabinoid. Grant

date/time interval

  • July 1, 2020 - May 31, 2026

awarded by

administered by

sponsor award ID

  • 5R01DA052271-05 / RDA052271A

local award ID

  • AWD000000011063

contributor